AZD1981 Bioavailability Study of Intravenous (IV) and Oral Formulations

Status:
Completed

Trial end date:
2009-07-01

Target enrollment:

Participant gender:

The primary objective is to investigate the pharmacokinetics of AZD1981 given in different formulations and to measure renal clearance

Phase 1

AstraZeneca